1. Home
  2. VABK vs MDXH Comparison

VABK vs MDXH Comparison

Compare VABK & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$38.36

Market Cap

206.8M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.19

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
MDXH
Founded
1998
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
183.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
VABK
MDXH
Price
$38.36
$3.19
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
11.0K
102.2K
Earning Date
04-23-2026
02-26-2026
Dividend Yield
3.77%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
$15.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.56
$1.36
52 Week High
$44.50
$5.33

Technical Indicators

Market Signals
Indicator
VABK
MDXH
Relative Strength Index (RSI) 44.24 38.45
Support Level $37.01 $3.05
Resistance Level $41.33 $3.78
Average True Range (ATR) 0.93 0.14
MACD -0.01 -0.01
Stochastic Oscillator 42.26 11.49

Price Performance

Historical Comparison
VABK
MDXH

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: